Status:
NOT_YET_RECRUITING
Ovarian Reserve in Intensive Care Patients
Lead Sponsor:
Haseki Training and Research Hospital
Conditions:
Anti-Mullerian Hormone Deficiency
Eligibility:
FEMALE
18-35 years
Brief Summary
Gastrointestinal, pulmonary, nephrological, cardiac, neurologic and psychological effects in critically ill patients followed in the intensive care unit have been shown in the literature. However, the...
Eligibility Criteria
Inclusion
- 18-35 years of age
- Female patients followed in the intensive care unit for more than 24 hours for internal or surgical reasons,
- Women whose ovarian reserve is being evaluated,
Exclusion
- Previous ovarian surgery, endometriosis, endometrioma,
- History of chemotherapy, radiotherapy,
- Ovarian cyst, malignancy and other ovarian pathologies,
- Women with single ovary,
- Women receiving hormone therapy,
- Polycystic ovary syndrome,
- Surgical intervention within the last 6 months,
- History of drug, alcohol, substance use,
- Women in pregnancy, puerperium, lactation,
- History of vaccination within the last 6 months
Key Trial Info
Start Date :
June 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 15 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06999291
Start Date
June 15 2025
End Date
November 15 2025
Last Update
May 31 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.